↓ Skip to main content

TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell…

Overview of attention for article published in BMC Cancer, April 2020
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
47 Mendeley